Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06223230

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Led by Renmin Hospital of Wuhan University · Updated on 2024-01-30

316

Participants Needed

1

Research Sites

212 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Aims to observe and evaluate the impact of survival and quality of life of patients with gastrointestinal tumors such as advanced esophageal, gastric, liver, pancreatic, and colorectal cancers through nutritional-psychological interventions versus no-vomit management compared to standard antitumor therapy alone

CONDITIONS

Official Title

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 75 years, male or female
  • Diagnosed with advanced esophageal, gastric, liver, colorectal, or other gastrointestinal cancers by pathological histology or cytology
  • Expected survival of at least 8 weeks and able to undergo long-term follow-up
  • Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 to 2
  • Receiving first-line standard oncology treatment combined with nutritional psychological intervention and vomit-free management or receiving only standard oncology treatment
  • Voluntarily signed informed consent form
Not Eligible

You will not qualify if you...

  • Diagnosed with other malignant tumors within the past 5 years, except effectively treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or effectively resected in situ cervical or breast cancer
  • History of psychiatric illness prior to tumor diagnosis
  • Patients who refuse treatment
  • Patients with poorly controlled severe heart disease, liver or kidney failure, severe anemia, multiple lymph node enlargement, leukopenia, or similar conditions
  • Pregnant or planning pregnancy
  • Patients judged by investigators as unsuitable for the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Renmin hosptial of Wuhan University

Wuhan, Hubei, China, 430060

Actively Recruiting

Loading map...

Research Team

Y

Yongshun Chen, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here